94 related articles for article (PubMed ID: 3679289)
21. Divergent effects of H-2K and H-2D genes on sensitivity of BL6 melanoma cells to NK cells or TNF-mediated cytotoxicity.
Kim M; Duty L; Herberman R; Gorelik E
Cell Immunol; 1994 May; 155(2):358-71. PubMed ID: 8181071
[TBL] [Abstract][Full Text] [Related]
22. Immunization with interleukin-2-secreting allogeneic mouse fibroblasts expressing melanoma-associated antigens prolongs the survival of mice with melanoma.
Kim TS; Russell SJ; Collins MK; Cohen EP
Int J Cancer; 1993 Nov; 55(5):865-72. PubMed ID: 8244584
[TBL] [Abstract][Full Text] [Related]
23. Macrophage MHC receptor 2: a novel receptor on allograft (H-2D(d)K(d))-induced macrophage (H-2D(b)K(b)) recognizing an MHC class I molecule, H-2K(d), in mice.
Tashiro-Yamaji J; Kubota T; Yoshida R
Gene; 2006 Dec; 384():1-8. PubMed ID: 17010536
[TBL] [Abstract][Full Text] [Related]
24. Attenuation of the Fas-L independent B16BL6 melanoma lymphocidic capacity by H-2K class I molecules.
Kellman-Pressman S; Fishman D; Tsory S; Segal S
Immunol Lett; 2005 Sep; 100(2):146-52. PubMed ID: 15935480
[TBL] [Abstract][Full Text] [Related]
25. Influence on metastasis of the reduction of major histocompatibility complex (MHC) class I gene with an antisense oligonucleotide.
Kanbe M; Arita D; Satoh T; Yokoyama A; Murakawa Y; Kikuchi H; Kanamaru R
Anticancer Drug Des; 1992 Aug; 7(4):341-50. PubMed ID: 1510801
[TBL] [Abstract][Full Text] [Related]
26. Partial purification of murine tumor-associated peptide epitopes common to histologically distinct tumors, melanoma and sarcoma, that are presented by H-2Kb molecules and recognized by CD8+ tumor-infiltrating lymphocytes.
Itoh T; Storkus WJ; Gorelik E; Lotze MT
J Immunol; 1994 Aug; 153(3):1202-15. PubMed ID: 7517974
[TBL] [Abstract][Full Text] [Related]
27. In vivo and in vitro analyses of the immunogenicity of B16 melanoma cells.
Heath W; Boyle W
Aust J Exp Biol Med Sci; 1985 Apr; 63 ( Pt 2)():163-75. PubMed ID: 3876093
[TBL] [Abstract][Full Text] [Related]
28. Resistance to melanoma in mice immunized with semiallogeneic fibroblasts transfected with DNA from mouse melanoma cells.
de Zoeten EF; Carr-Brendel V; Cohen EP
J Immunol; 1998 Mar; 160(6):2915-22. PubMed ID: 9510195
[TBL] [Abstract][Full Text] [Related]
29. Expression of two H-2K genes, syngeneic and allogeneic, as a strategy for potentiating immune recognition of tumor cells.
Mandelboim O; Vadai E; Feldman M; Eisenbach L
Gene Ther; 1995 Dec; 2(10):757-65. PubMed ID: 8750016
[TBL] [Abstract][Full Text] [Related]
30. Transfection and expression of syngeneic H-2 genes does not reduce malignancy of H-2 negative teratocarcinoma cells in the autologous host.
Ostrand-Rosenberg S; Cole GA; Nishimura MI; Clements VK
Cell Immunol; 1990 Jun; 128(1):152-64. PubMed ID: 2344619
[TBL] [Abstract][Full Text] [Related]
31. Immunity to melanoma in mice immunized with transfected allogeneic mouse fibroblasts expressing melanoma-associated antigens.
Kim YS; Slomski R; Cohen EP
Cancer Immunol Immunother; 1991; 34(3):163-8. PubMed ID: 1756533
[TBL] [Abstract][Full Text] [Related]
32. H-2Kb and H-2Db gene transfections in B16 melanoma differently affect non-immunological properties relevant to the metastatic process. Involvement of integrin molecules.
De Giovanni C; Nicoletti G; Sensi M; Santoni A; Palmieri G; Landuzzi L; Nanni P; Lollini PL
Int J Cancer; 1994 Oct; 59(2):269-74. PubMed ID: 7927928
[TBL] [Abstract][Full Text] [Related]
33. Radiation-enhanced expression of major histocompatibility complex class I antigen H-2Db in B16 melanoma cells.
Hauser SH; Calorini L; Wazer DE; Gattoni-Celli S
Cancer Res; 1993 Apr; 53(8):1952-5. PubMed ID: 8467514
[TBL] [Abstract][Full Text] [Related]
34. Induction and characterization of minor histocompatibility antigens. Specific primary cytotoxic T lymphocyte responses in vitro.
Ando K; Nakashima I; Nagase F; Isobe K; Kawashima K; Hasegawa Y; Yoshida T; Iwamoto T; Hasegawa T; Muro Y
J Immunol; 1988 Feb; 140(3):723-9. PubMed ID: 2448374
[TBL] [Abstract][Full Text] [Related]
35. Xenogenization of a mouse lung carcinoma (3LL) by transfection with an allogeneic class I major histocompatibility complex gene (H-2Ld).
Itaya T; Yamagiwa S; Okada F; Oikawa T; Kuzumaki N; Takeichi N; Hosokawa M; Kobayashi H
Cancer Res; 1987 Jun; 47(12):3136-40. PubMed ID: 3107804
[TBL] [Abstract][Full Text] [Related]
36. Genetic analysis of the presentation of minor lymphocyte stimulating determinants. I. Combined importance of MHC and non-MHC influences.
Ryan JJ; Mond JJ; Finkelman FD
J Immunol; 1988 Aug; 141(4):1063-73. PubMed ID: 3135319
[TBL] [Abstract][Full Text] [Related]
37. Evolution and expression of the transplantation antigen gene family.
Devlin JJ; Widera G; Mellor AL; Fahrner K; Sherman D; Weiss EH; Flavell RA
Fed Proc; 1985 Aug; 44(11):2736-40. PubMed ID: 3926542
[TBL] [Abstract][Full Text] [Related]
38. Increased projection of MHC and tumor antigens in murine B16-BL6 melanoma induced by hydrostatic pressure and chemical crosslinking.
Ramakrishna V; Eisenthal A; Skornick Y; Shinitzky M
Cancer Immunol Immunother; 1993 May; 36(5):293-9. PubMed ID: 8477415
[TBL] [Abstract][Full Text] [Related]
39. Impaired H-2 expression in B16 melanoma variants.
Nanni P; Colombo MP; De Giovanni C; Lollini PL; Nicoletti G; Parmiani G; Prodi G
J Immunogenet; 1983 Oct; 10(5):361-70. PubMed ID: 6644070
[TBL] [Abstract][Full Text] [Related]
40. Characterization of the major histocompatibility complex class I deficiencies in B16 melanoma cells.
Seliger B; Wollscheid U; Momburg F; Blankenstein T; Huber C
Cancer Res; 2001 Feb; 61(3):1095-9. PubMed ID: 11221838
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
